StonvexLoading…
StonvexStonvexStonvexCore line items from TROX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.90B | $3.07B | $2.85B | $3.45B |
Operating Income | $-253.00M | $219.00M | $186.00M | $458.00M |
Net Income | $-470.00M | $-48.00M | $-316.00M | $497.00M |
EPS (Diluted) | $-2.97 | $-0.31 | $-2.02 | $3.16 |
Total Assets | $6.22B | $6.04B | $6.13B | $6.31B |
Total Liabilities | $4.77B | $4.25B | $4.15B | $3.90B |
Cash & Equivalents | $199.00M | $151.00M | $273.00M | $164.00M |
Free Cash Flow OCF − CapEx | $-281.00M | $-70.00M | $-77.00M | $170.00M |
Shares Outstanding | 158.56M | 157.94M | 156.79M | 154.50M |